GNRH1 and ovarian hyperstimulation syndrome: Various strategies have been developed to minimize the risk of OHSS, including using lower doses of medication, using GnRH agonist triggering instead of human chorionic gonadotropin (hCG) triggering, and using freeze-all cycles.